HPS3
protein-codingHPS3 biogenesis of lysosomal organelles complex 2 subunit 1, the group of Biogenesis of lysosomal organelles complex 2
Gene summary
This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~44.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0016502
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013555
Submitter: ClinGen
The relationship between HPS3 and Hermasky-Pudlak syndrome 3, an autosomal recessive disorder, was evaluated using the ClinGen Clinical Validity Framework as of August 8, 2019. HPS3 was first reported in relation to Hermasky-Pudlak syndrome 3 in 2001 (Anikster, 2001, PMID: 11455388; Huizing, 2001, PMID: 11590544). At least 19 unique variants including nonsense, splice site, frameshift and large deletions have been reported in humans. Missense variants are not very common. HPS3 is involved in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Hermansky-Pudlak syndrome 3 is characterized by a mild phenotype compared to HPS1, with minimal hypopigmentation, ocular rather than oculocutaneous albinism and a mild bleeding diathesis (PMID: 20301464). It is generally not associated with pulmonary fibrosis or granulomatous colitis. Evidence supporting this gene-disease relationship includes case-level data, family data and experimental data. Summary of Case Level Data: 12 Points Variants in this gene have been reported in at least 7 probands in 5 publications (PMID: 11455388, 11590544, 28284561, 27593200, 30791930). Variants in the gene segregated with 4 additional family members (PMID: 11455388). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. The mechanism for disease is homozygous loss of function (PMID: 20301464) Summary of Experimental Data: 5 Points This gene-disease association is supported by mouse models and in vitro functional assays. The "cocoa" or "coa" mouse that carries at least 4 diferent spontaneously occurring mutations in the mouse Hps3 gene recapitulates the human HPS phenotype (PMID: 11707070, 14718540). HPS3 interacts with HPS5 and HPS6 to form BLOC-2, which is involved in the biogenesis of lysosome-related organelles (PMID: 15675963, 15632015, 15030569, 14718540). In summary, HPS3 is definitively associated with autosomal recessive Hermasky-Pudlak syndrome 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hemostasis/Thrombosis GCEP on February 26, 2020 (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0013555
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013555
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013555
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013555
Submitter: Natera
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary
Intervention: Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic
Rationale: Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPS
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HPS3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032383.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 414 | 1 | 429 | ||
| missense | 3 | 357 | 22 | 2 | 384 | |
| nonsense | 55 | 55 | 110 | |||
| start loss | 1 | 1 | 1 | 3 | ||
| frameshift | 129 | 95 | 2 | 226 | ||
| splice donor/acceptor (+/-2bp) | 7 | 34 | 7 | 48 | ||
| Total | 192 | 188 | 381 | 436 | 3 | 1200 |
Highest pathogenic variant AF is 0.000099185905
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_115759.2 | 17 | MANE Select | |
| Ensembl | ENSP00000296051.2 | 17 | MANE Select | |
| RefSeq | NP_001295187.1 | 16 | Standard | |
| Ensembl | ENSP00000418230.1 | 16 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- organelle organization
- pigmentation
Molecular Function
- protein binding
Cellular Component
- cytoplasm
- BLOC-2 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296051
- Coding exons
- 17
- Length
- 44149
- Individuals with no LoFs
- 125593
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 155
- Defined
- 125748
- p
- 0.000616
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.160 | 525 | 535 | 0.981 | 0.0000277 | 6529 |
| Missense (PolyPhen) | 263 | 276.53 | 0.95107 | 3491 | ||
| Synonymous | -0.378 | 215 | 208 | 1.03 | 0.0000110 | 1927 |
| Loss of Function | 1.44 | 38 | 48.9 | 0.778 | 0.00000239 | 641 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00062 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0.0018 | 0.0018 | notable |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00050 | 0.00050 | rare |
| South Asian | 0.0010 | 0.0010 | notable |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in early stages of melanosome biogenesis and maturation. {ECO:0000250|UniProtKB:Q91VB4}.;
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- LoFtool
- 0.961
- RVIS EVS
- -1.28
- RVIS percentile EVS
- 5.13
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.128
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |